Addition of Rituximab to High-Dose Methotrexate-Based Chemotherapy Improves Survival of Adults with Burkitt Lymphoma/Leukemia

Publisher： Karger

E-ISSN： 1421-9662|127|2|115-117

ISSN： 0001-5792

Source： Acta Haematologica, Vol.127, Iss.2, 2011-12, pp. : 115-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation

By Wolf T.   Kiderlen T.   Atta J.   Stephan C.   Kann G.   Brodt H.-R.   Brandts C.  

Infection, Vol. 42, Iss. 2, 2014-04 ,pp. : 445-447

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab with high‐dose methotrexate in primary central nervous system lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1149-1154

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement

By  

Acta Haematologica, Vol. 137, Iss. 2, 2017-01 ,pp. : 93-99

Karger

Access to resources Recommend Favorite

Rituximab‐combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : e30-e33

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 134-140

Karger

Access to resources Recommend Favorite